CALT: Gunggung utang perusahaan Calliditas

Calliditas Therapeutics (CALT) is integrating sustainability principles into the development of nephrology treatments, strictly adhering to ethical standards and environmental safety. The company is establishing a unique therapeutic environment to combat rare pathologies by offering an innovative method for preserving kidney function. Market fluctuations in the share price reflect the impact of Tarpeyo sales and expectations regarding an acquisition deal, while the separate_debt metric stands at 0.09.

Calliditas Therapeutics, Inc. - Utang perusahaan CALT (periode 04.07.2022 - 28.09.2024)

Rincian analitis lan laporan data perusahaan Calliditas Therapeutics (CALT)

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega calliditas.se|CALT - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Calliditas|CALT - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham Calliditas Therapeutics|CALT - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih calliditas.se|CALT - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Calliditas Therapeutics|CALT - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal calliditas.se|CALT - Utang perusahaan|Utang-utang marang kapitalisasi buku Calliditas|CALT - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Calliditas Therapeutics

Analisis umum perusahaan:CALT Calliditas Therapeutics, Inc.

Scaling sales of the renal pathology treatment under the control of a Japanese holding company requires precise capital management to minimize financial risks. The dynamics of total debt reflect the balance between utilizing leverage to drive profit growth and reducing the probability of default, demonstrating how the market currently prices in the credit load of Calliditas Therapeutics (CALT) in real time.

Pesaing wigati

Kewajiban utang agregat Travere Corp (TVTX)|Gunggung utang perusahaan ARDX (Ardelyx, Inc.)|prokidney.com - Gunggung utang perusahaan|Utang perusahaan Akebia Therapeutics, Inc. (AKBA)|TVRD: Kewajiban utang agregat|DMAC (DiaMedica Pharma) - Utang perusahaan|Unicycive Therapeutics, Inc (UNCY) - Gunggung utang perusahaan|RMTI (Rockwell Medical) - Gunggung utang perusahaan|Gunggung utang perusahaan cadrenal.com (CVKD)|Conduit Pharmaceuticals Inc. (CDT) - Gunggung utang perusahaan|Kewajiban utang agregat RNLX (Renalytix Plc)|Utang perusahaan ZVSA (ZyVersa Therapeutics, Inc.)